What are the major opportunities in the Leber Congenital Amaurosis market? What are the strategies for the Leber Congenital Amaurosis market?

For detailed insights on the major opportunities and strategies in the Leber Congenital Amaurosis market, Read More

How does the Leber Congenital Amaurosis market relate to the overall economy and other similar markets?

For detailed insights on Leber Congenital Amaurosis's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Leber Congenital Amaurosis market growth? SWOT analysis of the Leber Congenital Amaurosis market.

For detailed insights on the key dynamics influencing the Leber Congenital Amaurosis market growth and SWOT analysis of the Leber Congenital Amaurosis industry, Read More

Global Leber Congenital Amaurosis Market Report 2025

Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Leber Congenital Amaurosis Global Market Report 2025

Name: Leber Congenital Amaurosis Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Treatment Type (Gene Therapy, Pharmaceutical Drugs, Retinal Prosthesis, Assistive Devices, Other Treatments), By Age Of Onset ( Congenital Leber Congenital Amaurosis (LCA) (From Birth), Early Childhood Leber Congenital Amaurosis (LCA) (1-5 Years), Late-Onset Leber Congenital Amaurosis (LCA) (6 Years And Above)), By Distribution Channel (, Direct Tender, Retail Sales), By End User (Hospitals, Specialized Eye Clinics, Ophthalmology Research Centers, Home Care Settings, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Leber Congenital Amaurosis Market Overview

• Leber Congenital Amaurosis market size has reached to $1.01 billion in 2024

• Expected to grow to $1.31 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%

• Growth Driver: Rising Prevalence Of Inherited Retinal Diseases Driving The Growth Of The Market Due To Advancements In Genetic Testing And Diagnosis

• Market Trend: Advancing RNA-Based Treatments In The Market

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Leber Congenital Amaurosis Market?

Leber congenital amaurosis (LCA) is a genetic eye disorder that causes severe vision loss or blindness from infancy due to mutations affecting the retina’s ability to detect light. It is characterized by poor visual response, involuntary eye movements (nystagmus), and extreme farsightedness resulting from disrupted photoreceptor function and progressive retinal degeneration.

The main treatment types for leber congenital amaurosis (LCA) include Gene Therapy, pharmaceutical drugs, retinal prostheses, assistive devices, and other treatments. Gene therapy is a medical technique that uses genetic material to treat or prevent diseases, such as LCA, by correcting defective genes. The age of onset for LCA is categorized into congenital LCA (from birth), early childhood LCA (1–5 years), and late-onset LCA (6 years and above). Pharmaceutical drugs for LCA are distributed through various channels, including direct tender and retail sales, and are used by end users such as hospitals, specialized eye clinics, ophthalmology research centers, and home care settings.

Leber Congenital Amaurosis Market Size and growth rate 2025 to 2029: Graph

What Is The Leber Congenital Amaurosis Market Size 2025 And Growth Rate?

The leber congenital amaurosis market size has grown strongly in recent years. It will grow from $1.01 billion in 2024 to $1.06 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to rise in awareness of rare eye disorders, increased government funding, improved diagnostic techniques, expansion of ophthalmic research centers, patient advocacy initiatives.

What Is The Leber Congenital Amaurosis Market Growth Forecast?

The leber congenital amaurosis market size is expected to see strong growth in the next few years. It will grow to $1.31 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to growing investment in gene therapy, increasing prevalence of inherited retinal diseases, regulatory approvals for novel treatments, expanding clinical trials, and rising healthcare expenditure. Major trends in the forecast period include emergence of CRISPR-based therapies, increasing collaboration between biotech firms, development of personalized medicine, expansion of teleophthalmology, technological advancements in retinal imaging.

The forecast of 5.5% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. genetic medicine by inflating prices of retinal gene therapy vectors and specialized delivery devices sourced from the Netherlands and Canada, resulting in delayed treatment for rare blindness disorders and higher ophthalmic genetic therapy costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Leber Congenital Amaurosis Market Segmented?

1) By Treatment Type: Gene Therapy, Pharmaceutical Drugs, Retinal Prosthesis, Assistive Devices, Other Treatments

2) By Age Of Onset: Congenital Leber Congenital Amaurosis (LCA) (From Birth), Early Childhood Leber Congenital Amaurosis (LCA) (1-5 Years), Late-Onset Leber Congenital Amaurosis (LCA) (6 Years And Above)

3) By Distribution Channel:, Direct Tender, Retail Sales

4) By End User: Hospitals, Specialized Eye Clinics, Ophthalmology Research Centers, Home Care Settings, Other End Users

Subsegments:

1) By Gene Therapy: RPE65 Gene Replacement Therapy, CRISPR-Based Gene Editing, AAV (Adeno-Associated Virus) Vector Therapy, Emerging Experimental Gene Therapies

2) By Pharmaceutical Drugs: Retinoid-Based Therapies, Neuroprotective Agents, Anti-Inflammatory Drugs, Antioxidant Therapies

3) By Retinal Prosthesis: Implantable Retinal Chips, Artificial Retinal Stimulation Devices, Bionic Eye Technology

4) By Assistive Devices: Low Vision Aids, Screen Readers and Braille Devices, Mobility Aids for Vision Impairment

5) By Other Treatments: Stem Cell Therapy, Optogenetics-Based Treatments, Visual Rehabilitation Programs, Nutritional and Dietary Interventions

What Is Driving The Leber Congenital Amaurosis Market? Rising Prevalence Of Inherited Retinal Diseases Driving The Growth Of The Market Due To Advancements In Genetic Testing And Diagnosis

The increasing prevalence of inherited retinal diseases is expected to propel the growth of the leber congenital amaurosis (LCA) market. Inherited retinal diseases (IRDs) refer to genetic disorders affecting the retina, the light-sensitive tissue at the back of the eye responsible for vision. The increase in inherited retinal diseases is attributed to improving genetic testing, awareness and diagnosis, and longer life expectancy. Advancements in genetic testing have made it easier to diagnose inherited retinal diseases, leading to the identification of more cases. Leber congenital amaurosis helps advance the understanding of inherited retinal diseases by revealing genetic mutations and disease mechanisms that contribute to developing targeted therapies and treatments. For instance, in January 2025, according to the UK Parliament's House of Commons Library, a UK-based government administration, approximately 25,000 people in the UK were affected by inherited retinal diseases in 2024, an increase of 2% yearly. Therefore, the increasing prevalence of inherited retinal diseases drives the leber congenital amaurosis industry.

Who Are The Major Players In The Global Leber Congenital Amaurosis Market?

Major companies operating in the leber congenital amaurosis market are Sanofi S.A., Novartis AG, Astellas Pharma Inc., Invitae Corporation, Novelion Therapeutics Inc., Andelyn Biosciences Inc., CD Genomics Inc., Editas Medicine Inc., MeiraGTx Holdings plc, Sangamo Therapeutics Inc., LKC Technologies Inc., Aldeyra Therapeutics Inc., Asper Biogene OÜ, Allergan Inc., ProQR Therapeutics N.V., GenSight Biologics S.A., Ocugen Inc., IVERIC bio Inc. (formerly Ophthotech Corporation), Atsena Therapeutics Inc., HuidaGene Therapeutics Co. Ltd.

What Are The Key Trends Of The Global Leber Congenital Amaurosis Market? Advancing RNA-Based Treatments In The Market

Major companies operating in the leber congenital amaurosis market are focusing on developing innovative solutions, such as RNA-based treatments to improve vision restoration and disease management. RNA-based treatments use RNA molecules to treat diseases by targeting genetic processes. These include mRNA vaccines, siRNA therapies, antisense oligonucleotides, and RNA aptamers. For instance, in January 2025, Laboratoires Théa S.A.S., a France-based pharmaceutical company, launched Sepul Bio, a dedicated business unit aimed at advancing RNA therapies for inherited retinal diseases, explicitly targeting sepofarsen for leber congenital amaurosis 10 (LCA10) and ultevursen for USH2A-associated retinitis pigmentosa. With the successful dosing of the first patient in the LUNA Phase 2b clinical trial for ultevursen, Sepul Bio is poised to make significant strides in addressing these rare genetic disorders.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Leber Congenital Amaurosis Market? Ocuphire Pharma Acquired Opus Genetics To Advance Gene Therapy For Inherited Retinal Diseases

In October 2024, Ocuphire Pharma Inc., a US-based biopharmaceutical company, acquired Opus Genetics Inc. for an undisclosed amount. With this acquisition, Ocuphire Pharma aims to create a leading clinical-stage biotechnology company focused on developing gene therapies for inherited retinal diseases (IRDs). Opus Genetics Inc. is a US-based gene therapy company that develops treatments for inherited retinal diseases.

What Is The Regional Outlook For The Global Leber Congenital Amaurosis Market?

North America was the largest region in the leber congenital amaurosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Leber Congenital Amaurosis Market?

The leber congenital amaurosis (LCA) market consists of revenues earned by entities by providing services such as clinical trial services, healthcare and patient support services, vision rehabilitation services, and diagnostic testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The leber congenital amaurosis (LCA) market also includes sales of retinal implants, diagnostic testing kits, assistive devices, and gene therapies. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Leber Congenital Amaurosis Industry?

The leber congenital amaurosis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the leber congenital amaurosis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Leber Congenital Amaurosis Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.06 billion
Revenue Forecast In 2034	$1.31 billion
Growth Rate	CAGR of 5.5% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The leber congenital amaurosis market covered in this report is segmented – 1) By Treatment Type: Gene Therapy, Pharmaceutical Drugs, Retinal Prosthesis, Assistive Devices, Other Treatments 2) By Age Of Onset: Congenital Leber Congenital Amaurosis (LCA) (From Birth), Early Childhood Leber Congenital Amaurosis (LCA) (1-5 Years), Late-Onset Leber Congenital Amaurosis (LCA) (6 Years And Above) 3) By Distribution Channel:, Direct Tender, Retail Sales 4) By End User: Hospitals, Specialized Eye Clinics, Ophthalmology Research Centers, Home Care Settings, Other End Users Subsegments: 1) By Gene Therapy: RPE65 Gene Replacement Therapy, CRISPR-Based Gene Editing, AAV (Adeno-Associated Virus) Vector Therapy, Emerging Experimental Gene Therapies 2) By Pharmaceutical Drugs: Retinoid-Based Therapies, Neuroprotective Agents, Anti-Inflammatory Drugs, Antioxidant Therapies 3) By Retinal Prosthesis: Implantable Retinal Chips, Artificial Retinal Stimulation Devices, Bionic Eye Technology 4) By Assistive Devices: Low Vision Aids, Screen Readers and Braille Devices, Mobility Aids for Vision Impairment 5) By Other Treatments: Stem Cell Therapy, Optogenetics-Based Treatments, Visual Rehabilitation Programs, Nutritional and Dietary Interventions
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Sanofi S.A., Novartis AG, Astellas Pharma Inc., Invitae Corporation, Novelion Therapeutics Inc., Andelyn Biosciences Inc., CD Genomics Inc., Editas Medicine Inc., MeiraGTx Holdings plc, Sangamo Therapeutics Inc., LKC Technologies Inc., Aldeyra Therapeutics Inc., Asper Biogene OÜ, Allergan Inc., ProQR Therapeutics N.V., GenSight Biologics S.A., Ocugen Inc., IVERIC bio Inc. (formerly Ophthotech Corporation), Atsena Therapeutics Inc., HuidaGene Therapeutics Co. Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Leber Congenital Amaurosis Market Characteristics

3. Leber Congenital Amaurosis Market Trends And Strategies

4. Leber Congenital Amaurosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Leber Congenital Amaurosis Growth Analysis And Strategic Analysis Framework

5.1. Global Leber Congenital Amaurosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Leber Congenital Amaurosis Market Growth Rate Analysis

5.4. Global Leber Congenital Amaurosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Leber Congenital Amaurosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Leber Congenital Amaurosis Total Addressable Market (TAM)

6. Leber Congenital Amaurosis Market Segmentation

6.1. Global Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gene Therapy

Pharmaceutical Drugs

Retinal Prosthesis

Assistive Devices

Other Treatments

6.2. Global Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Congenital Leber Congenital Amaurosis (LCA) (From Birth)

Early Childhood Leber Congenital Amaurosis (LCA) (1-5 Years)

Late-Onset Leber Congenital Amaurosis (LCA) (6 Years And Above)

6.3. Global Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Direct Tender

Retail Sales

6.4. Global Leber Congenital Amaurosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialized Eye Clinics

Ophthalmology Research Centers

Home Care Settings

Other End Users

6.5. Global Leber Congenital Amaurosis Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

RPE65 Gene Replacement Therapy

CRISPR-Based Gene Editing

AAV (Adeno-Associated Virus) Vector Therapy

Emerging Experimental Gene Therapies

6.6. Global Leber Congenital Amaurosis Market, Sub-Segmentation Of Pharmaceutical Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Retinoid-Based Therapies

Neuroprotective Agents

Anti-Inflammatory Drugs

Antioxidant Therapies

6.7. Global Leber Congenital Amaurosis Market, Sub-Segmentation Of Retinal Prosthesis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Implantable Retinal Chips

Artificial Retinal Stimulation Devices

Bionic Eye Technology

6.8. Global Leber Congenital Amaurosis Market, Sub-Segmentation Of Assistive Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Low Vision Aids

Screen Readers and Braille Devices

Mobility Aids for Vision Impairment

6.9. Global Leber Congenital Amaurosis Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Stem Cell Therapy

Optogenetics-Based Treatments

Visual Rehabilitation Programs

Nutritional and Dietary Interventions

7. Leber Congenital Amaurosis Market Regional And Country Analysis

7.1. Global Leber Congenital Amaurosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Leber Congenital Amaurosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Leber Congenital Amaurosis Market

8.1. Asia-Pacific Leber Congenital Amaurosis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Leber Congenital Amaurosis Market

9.1. China Leber Congenital Amaurosis Market Overview

9.2. China Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Leber Congenital Amaurosis Market

10.1. India Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Leber Congenital Amaurosis Market

11.1. Japan Leber Congenital Amaurosis Market Overview

11.2. Japan Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Leber Congenital Amaurosis Market

12.1. Australia Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Leber Congenital Amaurosis Market

13.1. Indonesia Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Leber Congenital Amaurosis Market

14.1. South Korea Leber Congenital Amaurosis Market Overview

14.2. South Korea Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Leber Congenital Amaurosis Market

15.1. Western Europe Leber Congenital Amaurosis Market Overview

15.2. Western Europe Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Leber Congenital Amaurosis Market

16.1. UK Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Leber Congenital Amaurosis Market

17.1. Germany Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Leber Congenital Amaurosis Market

18.1. France Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Leber Congenital Amaurosis Market

19.1. Italy Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Leber Congenital Amaurosis Market

20.1. Spain Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Leber Congenital Amaurosis Market

21.1. Eastern Europe Leber Congenital Amaurosis Market Overview

21.2. Eastern Europe Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Leber Congenital Amaurosis Market

22.1. Russia Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Leber Congenital Amaurosis Market

23.1. North America Leber Congenital Amaurosis Market Overview

23.2. North America Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Leber Congenital Amaurosis Market

24.1. USA Leber Congenital Amaurosis Market Overview

24.2. USA Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Leber Congenital Amaurosis Market

25.1. Canada Leber Congenital Amaurosis Market Overview

25.2. Canada Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Leber Congenital Amaurosis Market

26.1. South America Leber Congenital Amaurosis Market Overview

26.2. South America Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Leber Congenital Amaurosis Market

27.1. Brazil Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Leber Congenital Amaurosis Market

28.1. Middle East Leber Congenital Amaurosis Market Overview

28.2. Middle East Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Leber Congenital Amaurosis Market

29.1. Africa Leber Congenital Amaurosis Market Overview

29.2. Africa Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Leber Congenital Amaurosis Market Competitive Landscape And Company Profiles

30.1. Leber Congenital Amaurosis Market Competitive Landscape

30.2. Leber Congenital Amaurosis Market Company Profiles

30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Invitae Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Novelion Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Leber Congenital Amaurosis Market Other Major And Innovative Companies

31.1. Andelyn Biosciences Inc.

31.2. CD Genomics Inc.

31.3. Editas Medicine Inc.

31.4. MeiraGTx Holdings plc

31.5. Sangamo Therapeutics Inc.

31.6. LKC Technologies Inc.

31.7. Aldeyra Therapeutics Inc.

31.8. Asper Biogene OÜ

31.9. Allergan Inc.

31.10. ProQR Therapeutics N.V.

31.11. GenSight Biologics S.A.

31.12. Ocugen Inc.

31.13. IVERIC bio Inc. (formerly Ophthotech Corporation)

31.14. Atsena Therapeutics Inc.

31.15. HuidaGene Therapeutics Co. Ltd.

32. Global Leber Congenital Amaurosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Leber Congenital Amaurosis Market

34. Recent Developments In The Leber Congenital Amaurosis Market

35. Leber Congenital Amaurosis Market High Potential Countries, Segments and Strategies

35.1 Leber Congenital Amaurosis Market In 2029 - Countries Offering Most New Opportunities

35.2 Leber Congenital Amaurosis Market In 2029 - Segments Offering Most New Opportunities

35.3 Leber Congenital Amaurosis Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Leber Congenital Amaurosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Leber Congenital Amaurosis Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Leber Congenital Amaurosis Market, Sub-Segmentation Of Pharmaceutical Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Leber Congenital Amaurosis Market, Sub-Segmentation Of Retinal Prosthesis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Leber Congenital Amaurosis Market, Sub-Segmentation Of Assistive Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Leber Congenital Amaurosis Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Leber Congenital Amaurosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Leber Congenital Amaurosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Sanofi S.A. Financial Performance

Table 81: Novartis AG Financial Performance

Table 82: Astellas Pharma Inc. Financial Performance

Table 83: Invitae Corporation Financial Performance

Table 84: Novelion Therapeutics Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Leber Congenital Amaurosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Leber Congenital Amaurosis Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Leber Congenital Amaurosis Market, Sub-Segmentation Of Pharmaceutical Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Leber Congenital Amaurosis Market, Sub-Segmentation Of Retinal Prosthesis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Leber Congenital Amaurosis Market, Sub-Segmentation Of Assistive Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Leber Congenital Amaurosis Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Leber Congenital Amaurosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Leber Congenital Amaurosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Leber Congenital Amaurosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Leber Congenital Amaurosis Market, Segmentation By Age Of Onset, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Leber Congenital Amaurosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Sanofi S.A. Financial Performance

Figure 81: Novartis AG Financial Performance

Figure 82: Astellas Pharma Inc. Financial Performance

Figure 83: Invitae Corporation Financial Performance

Figure 84: Novelion Therapeutics Inc. Financial Performance

Top Trends Driving Innovation and Change in the Interstitial Lung Disease Market: Innovative Drug Development Initiatives To Improve Interstitial Lung Disease Treatment

Global Intestinal Pseudo-Obstruction Treatment Market Projected to Reach $30.8 Billion by 2029 at a CAGR of 5.6%

Key Developments and Trends Steering the Intestine Cancer Therapeutics Market Forward: Increasing Focus On Product Approvals To Drive The Revenues

Major Trends and Emerging Patterns in the Intravenous Solutions Market: Innovative Syringes Transforming The Intravenous Solutions Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Congenital Heart Disease (CHD) Global Market Report 2025 – By Type (Heart Valve Defects, Heart Wall Defects, Blood Vessel Defects, Other Types), By Diagnosis (Electrocardiogram, Chest X-ray, Echocardiogram, Transesophag...

Progressive Multifocal Leukoencephalopathy Treatment Global Market Report 2025 – By Treatment (Anti-retroviral Therapy, Antiviral Or Anti-John Cunningham Virus (JCV), Other Symptomatic), By Indication (HIV Or AIDS, Organ...

Gaucher’s Disease Global Market Report 2025 – By Type (Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3, Other Types), By Diagnosis (Physical Exam, Blood Tests, Imaging Tests, Preconception Screenin...

Xerostomia Therapeutics Global Market Report 2025 – By Type (Artificial Saliva Or Saliva Substitutes, Salivary Stimulants), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmac...

Facial Paralysis Global Market Report 2025 – By Type (Bell’s Palsy, Ramsay Hunt Syndrome), By Diagnosis (Electromyography, Computerized Tomography), By Treatment (Medications, Physical Therapy), By End-User (Hospitals, S...

Hereditary Angioedema Therapeutics Global Market Report 2025 – By Drug Class (C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor, Other Drug Classes), By Route of Administration (Int...

Fabry Disease Treatment Global Market Report 2025 – By Treatment (Substrate Reduction Therapy, Enzyme Replacement Therapy, Chaperone Treatment, Other Treatments), By Route Of Administration (Oral Route, Intravenous Route...

Frequently Asked Questions

What is the definition of the Leber Congenital Amaurosis market?

How will the Leber Congenital Amaurosis market drivers and restraints affect the market dynamics? What forces will shape the Leber Congenital Amaurosis industry going forward?

The market major growth driver - Rising Prevalence Of Inherited Retinal Diseases Driving The Growth Of The Market Due To Advancements In Genetic Testing And Diagnosis. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Leber Congenital Amaurosis market?

The leber congenital amaurosis market size has grown steadily in recent years. It will grow from $1.01 billion in 2024 to $1.06 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to rise in awareness of rare eye disorders, increased government funding, improved diagnostic techniques, expansion of ophthalmic research centers, patient advocacy initiatives. The leber congenital amaurosis market size is expected to see strong growth in the next few years. It will grow to " $1.31 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to growing investment in gene therapy, increasing prevalence of inherited retinal diseases, regulatory approvals for novel treatments, expanding clinical trials, and rising healthcare expenditure. Major trends in the forecast period include emergence of CRISPR-based therapies, increasing collaboration between biotech firms, development of personalized medicine, expansion of teleophthalmology, technological advancements in retinal imaging. For further insights on this market, request a sample here

How is the Leber Congenital Amaurosis market segmented?

The leber congenital amaurosismarket covered in this report is segmented –
1) By Treatment Type: Gene Therapy; Pharmaceutical Drugs; Retinal Prosthesis; Assistive Devices; Other Treatments
2) By Age Of Onset: Congenital Leber Congenital Amaurosis (LCA) (From Birth); Early Childhood Leber Congenital Amaurosis (LCA) (1-5 Years); Late-Onset Leber Congenital Amaurosis (LCA) (6 Years And Above)
3) By Distribution Channel:; Direct Tender; Retail Sales
4) By End User: Hospitals; Specialized Eye Clinics; Ophthalmology Research Centers; Home Care Settings; Other End Users Subsegments:
1) By Gene Therapy: RPE65 Gene Replacement Therapy; CRISPR-Based Gene Editing; AAV (Adeno-Associated Virus) Vector Therapy; Emerging Experimental Gene Therapies
2) By Pharmaceutical Drugs: Retinoid-Based Therapies; Neuroprotective Agents; Anti-Inflammatory Drugs; Antioxidant Therapies
3) By Retinal Prosthesis: Implantable Retinal Chips; Artificial Retinal Stimulation Devices; Bionic Eye Technology
4) By Assistive Devices: Low Vision Aids; Screen Readers and Braille Devices; Mobility Aids for Vision Impairment
5) By Other Treatments: Stem Cell Therapy; Optogenetics-Based Treatments; Visual Rehabilitation Programs; Nutritional and Dietary Interventions For further insights on this market, request a sample here

Which region has the largest share of the Leber Congenital Amaurosis market? What are the other regions covered in the report?

North America was the largest region in the leber congenital amaurosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leber congenital amaurosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Leber Congenital Amaurosis market?

What are the key trends in the Leber Congenital Amaurosis market?

Major trends in this market include Advancing RNA-Based Treatments In The Market. For further insights on this market, request a sample here.